semaglutide and type 1 diabetes from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity Metabolic Liver Disorders Clinical trials show semaglutide may

10.1136/bmj.k872 300

23 September 2025

Top-line results of the Phase 2 trial demonstrated metopimazine led to a 40% reduction in the incidence of nausea and a 56% reduction in frequency of vomiting

Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer

Use In Specific Populations 8.1 Pregnancy Risk Summary Published studies with use of insulin glargine products during pregnancy have not reported a clear association with insulin glargine products and adverse developmental outcomes (see Data)

The letter references a 2024 recall of tablets, likely r the cancer medication cinacalcet or the thyroid medication levothyroxine sodium, both of which Intas recalled that year